Treatment with exogenous IFN-γ significantly enhanced MHC-I and WHSC1 expression in CRC organoid–derived tumors (Figure 7, D and E, and Supplemental Figure 5A). The gene discussed is IFNG; the disease is colorectal carcinoma.